09:16 AM EDT, 10/14/2025 (MT Newswires) -- Health care stocks were leaning lower pre-bell Tuesday, with the iShares Biotechnology ETF (IBB) down 0.8% and the Health Care Select Sector SPDR Fund ( XLV ) declining by 0.5%.

BioCryst Pharmaceuticals ( BCRX ) has agreed to acquire Astria Therapeutics ( ATXS ) in a deal valued at $700 million, the companies said. Astria Therapeutics ( ATXS ) shares were up more than 41% and BioCryst Pharmaceuticals ( BCRX ) shares were down more than 5% premarket.

Telix Pharmaceuticals (TLX) stock was up more than 4% after the company reported higher Q3 revenue and raised its 2025 revenue outlook.

Johnson & Johnson ( JNJ ) shares were up 0.1% after the company posted higher fiscal Q3 adjusted earnings and reported sales, and raised its 2025 reported sales guidance. Johnson & Johnson ( JNJ ) also said it plans to separate its orthopedics business into a standalone company operating as DePuy Synthes.